Physician profile
Thomas Leigh
NPI 1326055948
$3,075.76
in general payments reported to CMS, 2019-2025
34 companies · $593 in 2025
The $593 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $552 · 2020: $128 · 2021: $395 · 2022: $546 · 2023: $576 · 2024: $286 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,410 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,409.61 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $530.01 | 2019-2023 | |
| Astellas Pharma US INC | $310.96 | 2023-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $286.63 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $245.15 | 2021-2023 | |
| Daiichi Sankyo INC. | $219.36 | 2019-2023 | Injectafer |
| Pfizer INC. | $183.65 | 2020-2025 | |
| Hologic Sales and Service, LLC | $150.94 | 2019-2024 | Aptima |
| Sumitomo Pharma America, INC. | $140.78 | 2023-2025 | Gemtesa, Myfembree |
| Therapeuticsmd, INC. | $124.51 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.45 | 2019-2023 | |
| Myovant Sciences INC. | $78.33 | 2021-2022 | |
| Exeltis, USA INC. | $78.06 | 2021-2023 | Slynd |
| Duchesnay USA Incorporated | $72.80 | 2019 | |
| Caldera Medical, INC | $66.74 | 2023 | Desara |
| Organon LLC | $53.57 | 2022-2024 | Nexplanon |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $45.39 | 2021-2022 | |
| Millicent US INC | $45.00 | 2025 | |
| Shield Therapeutics INC | $43.64 | 2024 | |
| Allergan, INC. | $36.44 | 2019 | |
| Medline Industries Lp | $30.65 | 2019 | |
| Coopersurgical, INC. | $29.34 | 2020 | |
| Agile Therapeutics, INC. | $26.09 | 2021-2022 | |
| Roche Diagnostics Corporation | $23.46 | 2019 | |
| Bausch Health US, LLC | $16.28 | 2021 | |
| Minerva Surgical, INC | $14.68 | 2020 | |
| Meditrina | $14.40 | 2019 | |
| Evofem Biosciences, INC. | $14.29 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.28 | 2019 | |
| Cepheid | $13.93 | 2019 | |
| Acessa Health INC. | $13.90 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.26 | 2019 | |
| Kci USA, INC. | $13.08 | 2020 | |
| Avion Pharmaceuticals | $11.41 | 2019 | |
| Channel Medsystems, INC. | $9.30 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Leigh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.